Source:http://linkedlifedata.com/resource/pubmed/id/10488967
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0003595,
umls-concept:C0004153,
umls-concept:C0013443,
umls-concept:C0024554,
umls-concept:C0027051,
umls-concept:C0031437,
umls-concept:C0032105,
umls-concept:C0041004,
umls-concept:C0239307,
umls-concept:C0241888,
umls-concept:C0262926,
umls-concept:C0332119,
umls-concept:C0376674,
umls-concept:C0441889,
umls-concept:C0521421,
umls-concept:C0681814,
umls-concept:C1280500,
umls-concept:C1414437,
umls-concept:C2603343
|
pubmed:issue |
2
|
pubmed:dateCreated |
1999-10-13
|
pubmed:abstractText |
The goal of the present study was to assess whether the effect of the apolipoprotein E polymorphism on postprandial lipemia explained part of the risk attributable to familial history of coronary heart disease. Cases (n = 407) were students, aged between 18 and 28 years, whose fathers had a proven myocardial infarction before the age of 55 years. Age-matched controls (n = 415) were recruited from the corresponding student registers. Blood was obtained after an overnight fast and at 2, 3, 4 and 6 h after ingestion of a fatty meal for triglyceride measurements. Apolipoprotein E phenotype was associated with postprandial triglyceride variability in both cases and controls. However, the apolipoprotein E-dependent triglyceride response was not significantly heterogeneous between cases and controls. In the pooled data, postprandial triglyceride levels were higher in carriers of the E2 and, to a lesser extent, of the E4 isoform, than in E3/3 homozygotes, independently of fasting triglyceride levels. At 6 h, triglyceride levels were increased by 21.2% (P < 0.01) in E2 carriers and 11.5% (P = 0.053) in E4 carriers by comparison to E3/3 subjects. These effects were not significantly different between regions. In conclusion, the effects of the apolipoprotein E polymorphism on postprandial triglyceridemia are similar across regions of Europe, and homogeneous in healthy young subjects with and without a family history of early myocardial infarction. This suggests that the influence of apolipoprotein E on myocardial infarction risk may be acting through mechanisms other than through effects on postprandial triglyceridemia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Apolipoproteins E,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/Dietary Fats,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0021-9150
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
381-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10488967-Adolescent,
pubmed-meshheading:10488967-Adult,
pubmed-meshheading:10488967-Alleles,
pubmed-meshheading:10488967-Apolipoproteins E,
pubmed-meshheading:10488967-Cholesterol, HDL,
pubmed-meshheading:10488967-Cholesterol, LDL,
pubmed-meshheading:10488967-Dietary Fats,
pubmed-meshheading:10488967-Gene Frequency,
pubmed-meshheading:10488967-Genetic Predisposition to Disease,
pubmed-meshheading:10488967-Humans,
pubmed-meshheading:10488967-Male,
pubmed-meshheading:10488967-Middle Aged,
pubmed-meshheading:10488967-Myocardial Infarction,
pubmed-meshheading:10488967-Phenotype,
pubmed-meshheading:10488967-Polymorphism, Genetic,
pubmed-meshheading:10488967-Postprandial Period,
pubmed-meshheading:10488967-Risk Factors,
pubmed-meshheading:10488967-Triglycerides
|
pubmed:year |
1999
|
pubmed:articleTitle |
Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study.
|
pubmed:affiliation |
Département d'athérosclérose and INSERM U-508, Institut Pasteur, Lille, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|